ICCM logo

ICCM
Icecure Medical Ltd

2,755
Mkt Cap
$16.49M
Volume
129,484.00
52W High
$1.40
52W Low
$0.2375
PE Ratio
-1.02
ICCM Fundamentals
Price
$0.2405
Prev Close
$0.24
Open
$0.2464
50D MA
$0.4372
Beta
0.93
Avg. Volume
535,468.20
EPS (Annual)
-$0.2368
P/B
1.94
Rev/Employee
$48,971.01
$30.11
Loading...
Loading...
News
all
press releases
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
The Oncology Institute (TOI) delivered earnings and revenue surprises of +71.43% and +1.54%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
More News
News Placeholder
IceCure Showcases ProSense Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market
IceCure Showcases ProSense Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market IceCure Showcases ProSense Cryoablation at...
PR Newswire·6d ago
News Placeholder
IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025
IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 IceCure Participates in Society...
PR Newswire·20d ago
News Placeholder
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private...
PR Newswire·2mo ago
News Placeholder
IceCure Medical Reports Positive Trial Results For ProSense Cryoablation System
(RTTNews) - IceCure Medical Ltd. (ICCM) on Wednesday, has reported favorable top-line results from its ICESECRET clinical trial, which assessed the ProSense Cryoablation System for the treatment of...
Nasdaq News: Markets·2mo ago
News Placeholder
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates IceCure Reports Positive 5-Year Top-Line Results from ICESECRET...
PR Newswire·2mo ago
News Placeholder
IceCure Medical Appoints Meir Peleg As CFO; Shares Rise In Pre-market
(RTTNews) - IceCure Medical Ltd. (ICCM), on Tuesday, appointed Meir Peleg as Chief Financial Officer, effective May 17...
Nasdaq News: Markets·2mo ago
News Placeholder
IceCure Appoints Meir Peleg as Chief Financial Officer
IceCure Appoints Meir Peleg as Chief Financial Officer IceCure Appoints Meir Peleg as Chief Financial Officer PR Newswire CAESAREA, Israel, March 24, 2026 Meir Peleg brings over 20 years of financial...
PR Newswire·2mo ago
News Placeholder
IceCure Medical (ICCM) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·2mo ago
News Placeholder
IceCure Reports 2025 Full Year Financial & Operational Results
IceCure Reports 2025 Full Year Financial & Operational Results IceCure Reports 2025 Full Year Financial & Operational Results PR Newswire CAESAREA, Israel, March 17, 2026 Record 4th quarter and full...
PR Newswire·2mo ago
<
1
2
...
>

Latest ICCM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.